|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| REVENUES | |||||
| COST OF REVENUES | |||||
| GROSS PROFIT | |||||
| OPERATING EXPENSES: | |||||
| Research and development | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| LOSS FROM OPERATIONS | |||||
| FINANCIAL INCOME, net: | |||||
| LOSS BEFORE TAX EXPENSES | |||||
| TAX EXPENSES | |||||
| NET LOSS | |||||
| NET LOSS PER SHARE - basic | |||||
| NET LOSS PER SHARE - diluted | |||||
| WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING NET LOSS PER SHARE - basic | |||||
| WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING NET LOSS PER SHARE - diluted | |||||
Loading...